Acorns Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Acorns Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$509K	Sell	12,107 -71	-0.6%	-$2.26K	﹤0.01%	72
2026 Q1	$322K	Buy	12,178 +1,528	+14%	+$44.7K	﹤0.01%	84
2025 Q4	$309K	Buy	10,650 +1,245	+13%	+$37.4K	﹤0.01%	81
2025 Q3	$261K	Buy	9,405 +728	+8%	+$18.4K	﹤0.01%	81
2025 Q2	$211K	Buy	+8,677	New	+$190K	﹤0.01%	82

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Acorns Advisers's ARKG Position: Q2 2026 in Review

Acorns Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.58% in Q2 2026, selling an estimated $2.26K and leaving 12,107 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #72.

Acorns Advisers first reported a position in ARKG in Q2 2025 and has held it in 5 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Acorns Advisers held 12,107 shares of ARK Genomic Revolution ETF worth $509K as of Q2 2026.
Acorns Advisers sold 71 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.26K.
ARK Genomic Revolution ETF made up ﹤0.01% of Acorns Advisers's portfolio in Q2 2026, its #72 holding.
Acorns Advisers first reported a position in ARK Genomic Revolution ETF in Q2 2025 and has held it in 5 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Acorns Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.